Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CYTR $2.50 0.3700 +17.37%
SRNE $5.52 0.6300 +12.88%
ATRA $15.41 1.4000 +9.99%
BPMC $16.26 1.4200 +9.57%
CRIS $1.44 0.1200 +9.09%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.43 -0.0298 -6.48%
CBMG $16.43 -0.4600 -2.72%
APRI $1.14 -0.0300 -2.56%
CERU $1.95 -0.0400 -2.01%
RNN $0.36 -0.0069 -1.87%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Why Donald Trump Would Have The Same Problems As Democrats On Medicare Drug Prices

(STAT) Jan 26, 2016 - Donald Trump stunned the health care world Monday night with his call for Medicare to negotiate drug prices — an idea that’s straight out of Hillary Clinton’s and Bernie Sanders playbooks, and one that other Republicans won’t touch.
read article 

US Insurers Dragging Feet On Covering New Drugs, Novartis Says

(Reuters) Jan 27, 2016 - Getting U.S. government and commercial insurers to cover new medicines can now take longer than in Europe, Swiss drugmaker Novartis said on Wednesday, blaming U.S. delays for weaker than expected sales of a key heart failure treatment.
read article 

NICE Backs Five Cancer Drugs, Spurns Cyramza

(BioCentury) Jan 26, 2016 - The U.K.'s NICE recommended a quintet of cancer drugs, including reversing a prior decision on Farydak panobinostat from Novartis AG; however, the agency snubbed stomach cancer compound Cyramza ramucirumab from Eli Lilly and Co.
read article 

Appalachia Continues to Have Higher Cancer Incidence Rates Than the Rest of the United States but Gap is Narrowing

(AACR) Jan 27, 2016 - Men and women in Appalachia continue to have higher cancer incidence rates compared with those in the rest of the United States regardless of race or location.
read press release 

AG Calls On Gilead To Lower Price Of Hepatitis C Medicines

(Boston Globe) Jan 27, 2016 - State Attorney General Maura Healey is warning Gilead Sciences Inc. it faces possible legal action unless it lowers the price of two popular hepatitis C medicines.
read article (free registration required) 

Task Force: Doctors Should Screen All Adults For Depression

(USA Today) Jan 26, 2016 - Primary care doctors should screen all adults for depression, an expert panel recommended Tuesday.
read article 

ASCO Publishes Core Curriculum for Cancer Survivorship Education

(ASCO in Action) Jan 26, 2016 - On January 26, the Journal of Oncology Practice (JOP) published an “ASCO Core Curriculum for Cancer Survivorship Education,” a set of recommended content areas and core competencies to be used to guide the education and training of physicians and other allied health professionals in addressing the needs of the growing number of cancer survivors.
read article 

Cancer Riddle, Solved

(University of Iowa/Iowa Now) Jan 25, 2016 - University of Iowa researchers reveal how cancer cells form tumors.
read article 

Home or Away? Award to Study Post-chemo Recovery for Children with Leukemia

(CHOP) Jan 27, 2016 - After children with leukemia receive a course of chemotherapy at a hospital, are they better off remaining in the hospital, or going home with their families?
read article 

ImmunoCellular Therapeutics Enters into a Sponsored Research Agreement with The University of Maryland, Baltimore to Pursue Multiple Enhancements of its Cancer Immunotherapy Platforms

(4-traders) Jan 27, 2016 - ImmunoCellular Therapeutics, Ltd. today announced it has entered into a sponsored research agreement with Eduardo Davila, PhD, Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine, and the University of Maryland, Baltimore.
read article 

ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO® (nivolumab)

(TheStreet) Jan 26, 2016 - Japan-based pharma deploys Medidata Rave® to capture, manage and report patient data for clinical trials testing Opdivo against broad range of cancers.
read article 

Cancer Kills 7,500 Daily in China

(Yahoo! News/AFP) Jan 27, 2016 - Chronic infections, smoking and pollution have contributed to skyrocketing cases of cancer in China, with an estimated 4.3 million new diagnoses last year and 2.8 million deaths, researchers said Tuesday.
read article 

Recommendation to Omit Radiation Therapy after Lumpectomy for Some Breast Cancer Patients Is Frequently Not Implemented in Clinical Practice

(American College of Surgeons) Jan 27, 2016 - Nearly two thirds of U.S. women age 70 or older with stage I breast cancer who undergo lumpectomy and are eligible to safely omit subsequent radiation therapy (RT) according to national cancer guidelines still receive this treatment, according to new study results.
read press release 

Experts: High Drug Price Trend Has “Infected” Generics

(ASH) Jan 27, 2016 - An article published online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that pharmaceutical companies use several strategies to keep affordable generic drugs from the market, illustrating an emerging trend that authors say is becoming as harmful to consumers as high-cost brand-name drugs.
read press release 

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

(MSK) Jan 27, 2016 - Together we, the National Cancer Institute (NCI)-designated Cancer Centers, recognize these low rates of HPV vaccination as a serious public health threat.
read article 

AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial In Patients With Relapsed Stage III Or IV Ovarian Cancer

(Yahoo! Finance) Jan 26, 2016 - AVAX Technologies, Inc., a pioneer in personalized cancer vaccines, today announced the results of its Phase 1/2 OVAX study in patients with platinum resistant relapsed Stage III or IV Ovarian Cancer.
read article 

BIND Therapeutics Provides Enrollment Update for Phase 2 iNSITE 1 and iNSITE 2 Trials with BIND-014

(Morningstar) Jan 27, 2016 - BIND Therapeutics, Inc. today announced that the iNSITE 1 trial in non-small cell lung cancer (NSCLC) with squamous histology is fully enrolled and data is expected to be available by the end of the first quarter of 2016.
read article 

Clovis Oncology Initiates Immunotherapy Combination Trial

(Clovis Oncology) Jan 27, 2016 - Study to evaluate the combination of rociletinib (CO-1686) with Genentech’s atezolizumab (MPDL3280A) for patients with advanced EGFR-mutant non-small cell lung cancer.
read corporate press release 

Important Falls In Death Rates From Leukemia In Europe Predicted For 2016

(ESMO) Jan 27, 2016 - Death rates from leukaemia among people of all ages in Europe are falling, according to the latest predictions for European cancer deaths in 2016, published in the leading cancer journal Annals of Oncology today.
read press release 

Study Shows Inferior Outcomes for African-American Pediatric Lymphoma Patients

(University of Miami/Miller School of Medicine) Jan 26, 2016 - Researchers from Sylvester Comprehensive Cancer Center have published a study showing that African-American pediatric Hodgkin lymphoma patients have inferior overall survival to their white and Hispanic peers.
read article 

Nivolumab Combined with Radiation Therapy May Be New Treatment Option for Patients with Melanoma Brain Metastases, Say Moffitt Cancer Center Researchers

(Moffitt) Jan 27, 2016 - The PD-1 targeting drug Nivolumab combined with stereotactic radiation resulted in minimal neurotoxicity in brain metastatic melanoma patients.
read press release 

Survival Period for Esophageal Cancer Is Tied to Race and Income

(Duke Medicine) Jan 26, 2016 - African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers.
read press release 

Smoking Lowers Breast Cancer Survival, Study Finds

(Philadelphia Inquirer/HealthDay News) Jan 26, 2016 - Women diagnosed with breast cancer who continue to smoke cigarettes are less likely to survive than those who never smoked or those who quit, new research finds.
read article 

Smokers Who Quit More Than 15 Years Ago Need Screening

(Mayo Clinic) Jan 26, 2016 - Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study by Mayo Clinic researchers published in the Journal of Thoracic Oncology.
read press release 

NHS Cancer Patients Gain Access To Four New Therapies

(PharmaTimes [UK]) Jan 27, 2016 - The National Institute for Health and Care Excellence has issued final recommendations endorsing National Health Service use of new therapies for ovarian cancer, multiple myeloma and prostate cancer, but rejecting one for gastric cancer.
read article